Healthcare Services

Global Veterinary Clinical Trials Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Veterinary Clinical Trials Market Over The Period 2026–2030?

The veterinary clinical trials market has observed substantial expansion in recent years. Its size is projected to increase from $4.85 billion in 2025 to $5.32 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. This historic growth is primarily attributed to several factors: an increase in veterinary pharmaceutical research, growing rates of pet ownership, a heightened demand for evidence-based veterinary treatments, the expansion of academic research programs, and improvements in regulatory frameworks for animal trials.

The veterinary clinical trials market size is projected for substantial expansion over the upcoming years. This market is predicted to reach $7.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth throughout the forecast period stems from factors such as heightened investments in veterinary drug development, the increasing embrace of precision medicine for animals, the broadening involvement of Contract Research Organizations (CROs) in veterinary trials, an intensifying focus on chronic and oncology conditions, and greater utilization of real-world evidence in animal health. Key trends anticipated during this period encompass the wider adoption of digital trial management platforms, an increase in genomic and biomarker-based studies, a strengthened focus on clinical research involving companion animals, the proliferation of multicenter veterinary trials, and a heightened commitment to data integrity and compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20683&type=smp

What Drivers Are Expected To Influence The Veterinary Clinical Trials Market During The Forecast Period?

An anticipated increase in pet owners is projected to boost the expansion of the veterinary clinical trials market in the future. Pet ownership refers to the act of keeping and looking after one or more animals as companions within a household. This surge in pet ownership stems from various elements, such as the longing for companionship, the advantages of animal-assisted therapy, and a heightened understanding of how pets positively influence mental and physical health. Veterinary clinical trials, in turn, benefit pet owners by offering improved access to advanced pet treatments and elevating veterinary care, which leads to superior health results for animals. Moreover, these trials are instrumental in creating treatments that are both safer and more efficacious. An example is the data from June 2025 by Petfood Industry, a US-based pet food manufacturer, indicating that around 68 million dogs were kept by American households in their latest survey, an increase from 65.1 million recorded in the 2023–2024 study. Consequently, the growing population of pet owners is acting as a catalyst for the expansion of the veterinary clinical trials market.

How Is The Veterinary Clinical Trials Market Divided Into Its Major Segments?

The veterinary clinical trials market covered in this report is segmented –

1) By Animal: Livestock Animal, Companion Animal, Other Animals

2) By Indications: Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indications

3) By Intervention: Medicines, Medical Devices, Other Interventions

4) By End-Users: Academics And Research Centers, Pharmaceutical And Biopharmaceutical Companies, Other End-Users

Subsegments:

1) By Livestock Animal: Cattle, Sheep, Goats, Swine, Poultry

2) By Companion Animal: Dogs, Cats, Horses, Rabbits, Ferrets

3) By Other Animals: Wildlife, Exotic Pets, Laboratory Animals, Aquatic Animals

How Are Trends Transforming The Veterinary Clinical Trials Market Landscape?

Leading companies within the veterinary clinical trials market are increasingly focused on developing innovative anti-aging medications to extend pet longevity and enhance overall animal health. These novel anti-aging drugs are defined as advanced pharmaceuticals crafted to impede or reverse the effects of aging, thereby improving the health and vigor of older animals. For example, in February 2024, Loyal, a US-based veterinary company, initiated a clinical trial for LOY-002, a new anti-aging drug aimed at prolonging the healthy lifespan of senior dogs. This drug is formulated to boost metabolic health in dogs, addressing age-related alterations that frequently lead to diverse health complications. The chewable pill, developed specifically for older dogs of most sizes (excluding the smallest breeds), is presently undergoing evaluation in the STAY study, which intends to enroll over 1,000 dogs aged 10 and older from more than 50 veterinary clinics across the United States. LOY-002’s main objective is to improve metabolic function, which could potentially postpone age-related diseases and elevate the overall quality of life for aging dogs.

Who Are The Prominent Organizations Shaping The Veterinary Clinical Trials Market?

Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill’s Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management

Read the full veterinary clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-clinical-trials-global-market-report

Which Region Is Forecast To Lead The Veterinary Clinical Trials Market In Terms Of Market Size?

North America was the largest region in the veterinary clinical trials market in 2025. The regions covered in the veterinary clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Veterinary Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20683&type=smp

Browse Through More Reports Similar to the Global Veterinary Clinical Trials Market 2026, By The Business Research Company

Companion Animal Veterinary Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Veterinary Disposables Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-disposables-global-market-report

Veterinary Imaging Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795